NCT00089245 2023-12-26Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal CancerY-mAbs TherapeuticsPhase 1 Terminated177 enrolled
NCT02736565 2023-11-13Pbi-shRNAâ„¢ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's SarcomaGradalis, Inc.Phase 1 Completed7 enrolled
NCT01585649 2016-05-18PK/PD of XM22 in Children With Ewing Family of Tumors or RhabdomyosarcomaTeva Branded Pharmaceutical Products R&D, Inc.Phase 1 Completed21 enrolled